Mosqueira, D., Mannhardt, I., Bhagwan, J. R., Lis-Slimak, K., Katili, P., Scott, E., . . . Denning, C. (2018). CRISPR/Cas9 editing in human pluripotent stem cell-cardiomyocytes highlights arrhythmias, hypocontractility, and energy depletion as potential therapeutic targets for hypertrophic cardiomyopathy. Oxford University Press.
Chicago Style (17th ed.) CitationMosqueira, Diogo, et al. CRISPR/Cas9 Editing in Human Pluripotent Stem Cell-cardiomyocytes Highlights Arrhythmias, Hypocontractility, and Energy Depletion as Potential Therapeutic Targets for Hypertrophic Cardiomyopathy. Oxford University Press, 2018.
MLA (9th ed.) CitationMosqueira, Diogo, et al. CRISPR/Cas9 Editing in Human Pluripotent Stem Cell-cardiomyocytes Highlights Arrhythmias, Hypocontractility, and Energy Depletion as Potential Therapeutic Targets for Hypertrophic Cardiomyopathy. Oxford University Press, 2018.